ISDA: 3CCN

Deposition Date 2008-02-26

Release Date 2008-04-29

Last Version Date 2023-08-30

Entry Detail

PDB ID:

3CCN

Keywords:

TRANSFERASE

Title:

X-ray structure of c-Met with triazolopyridazine inhibitor.

Biological Source:

Source Organism(s):

Homo sapiens (Taxon ID: 9606)

Expression System(s):

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.90 Å

R-Value Free:

0.27

R-Value Work:

0.23

R-Value Observed:

0.23

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Hepatocyte growth factor receptor
Gene (Uniprot):MET
Chain IDs:A
Chain Length:310
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08581 Pfam ID:PF07714 EC:2.7.10.1

Ligand Molecules

LKG

Primary Citation

Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase.

Albrecht, B.K, Harmange, J.C, Bauer, D, Berry, L, Bode, C, Boezio, A.A, Chen, A, Choquette, D, Dussault, I, Fridrich, C, Hirai, S, Hoffman, D, Larrow, J.F, Kaplan-Lefko, P, Lin, J, Lohman, J, Long, A.M, Moriguchi, J, O'Connor, A, Potashman, M.H, Reese, M, Rex, K, Siegmund, A, Shah, K, Shimanovich, R, Springer, S.K, Teffera, Y, Yang, Y, Zhang, Y, Bellon, S.F.Show

J.Med.Chem. 51 2879 2882 (2008)

PMID: 18426196 DOI: 10.1021/jm800043g

Abstact

Tumorigenesis is a multistep process in which oncogenes play a key role in tumor formation, growth, and maintenance. MET was discovered as an oncogene that is activated by its ligand, hepatocyte growth factor. Deregulated signaling in the c-Met pathway has been observed in multiple tumor types. Herein we report the discovery of potent and selective triazolopyridazine small molecules that inhibit c-Met activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form